Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis
Authors
Keywords
-
Journal
INFLAMMATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-19
DOI
10.1007/s10753-019-01106-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Coming Decade of Cell Death Research: Five Riddles
- (2019) Douglas R. Green CELL
- Caspases in Cell Death, Inflammation, and Disease
- (2019) Nina Van Opdenbosch et al. IMMUNITY
- Salidroside Reduces Inflammation and Brain Injury After Permanent Middle Cerebral Artery Occlusion in Rats by Regulating PI3K/PKB/Nrf2/NFκB Signaling Rather than Complement C3 Activity
- (2019) X. Zhang et al. INFLAMMATION
- Neferine inhibits LPS-ATP-induced endothelial cell pyroptosis via regulation of ROS/NLRP3/Caspase-1 signaling pathway
- (2019) Yang-Shuo Tang et al. INFLAMMATION RESEARCH
- NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy
- (2019) Negin Parsamanesh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Defective autophagy in vascular smooth muscle cells enhances cell death and atherosclerosis
- (2018) Yusuke Osonoi et al. Autophagy
- Pyroptosis and its relationship to atherosclerosis
- (2018) Yuan-Jun Xu et al. CLINICA CHIMICA ACTA
- Salidroside attenuates endothelial cellular senescence via decreasing the expression of inflammatory cytokines and increasing the expression of SIRT3
- (2018) Sha-Sha Xing et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis
- (2018) Xianxian Wu et al. Cell Death & Disease
- Role of pyroptosis in cardiovascular diseases
- (2018) Chang Jia et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis
- (2017) Yong Zhang et al. JOURNAL OF PINEAL RESEARCH
- NLRP3 inflammasome: a novel link between lipoproteins and atherosclerosis
- (2016) Wang Li Li et al. Archives of Medical Science
- Endothelial cells: source, barrier, and target of defensive mediators
- (2016) Lubka T. Roumenina et al. IMMUNOLOGICAL REVIEWS
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
- (2015) Wan-ting He et al. CELL RESEARCH
- Anti-Inflammatory and Antiatherogenic Effects of the NLRP3 Inflammasome Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet
- (2015) A. Abderrazak et al. CIRCULATION
- Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway
- (2015) Xiaoying Huang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway
- (2015) Sha-Sha Xing et al. VASCULAR PHARMACOLOGY
- Mechanism of NLRP3 inflammasome activation
- (2014) Fayyaz S. Sutterwala et al. Annals of the New York Academy of Sciences
- Procyanidin B2 inhibits NLRP3 inflammasome activation in human vascular endothelial cells
- (2014) Haixia Yang et al. BIOCHEMICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started